Related Experiment Video
Updated: Jul 2, 2025

08:36
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
512
How Treatment Effect Heterogeneity Works.
C Corey Hardin1, Michael Fralick2, Daniel Muller
1Massachusetts General Hospital, Boston, Massachusetts.
NEJM Evidence
|February 27, 2024
Summary
Treatment effect heterogeneity means treatments work differently for each person. Understanding these differences is key to applying clinical trial results effectively in real-world patient care.
Area of Science:
- Biostatistics
- Clinical Trial Methodology
- Translational Medicine
Background:
- Clinical trials aim to evaluate treatment efficacy.
- Individual patient responses to treatments can vary significantly.
- Treatment effect heterogeneity addresses these variations.
Discussion:
- Understanding heterogeneity is crucial for personalized medicine.
- It impacts the generalizability of clinical trial findings.
- Statistical methods are employed to identify and quantify heterogeneity.
Key Insights:
- Treatment effectiveness is not uniform across all participants.
- Recognizing subgroup effects improves treatment application.
- Heterogeneity analysis enhances the interpretation of trial outcomes.
Outlook:
- Future research should focus on predictive modeling for treatment response.
- Integrating heterogeneity into clinical guidelines will optimize patient care.
- Advancements in data analysis will further elucidate treatment variations.
Related Concept Videos
The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
Factors Affecting Drug Biotransformation: Biological
149
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
149

